Companies / BOC Sciences / Odronextamab
BOC Sciences

Odronextamab | BOC Sciences

Odronextamab is a human bispecific antibody that binds CD3 on T cells and CD20 on B cells. Odronextamab has been used in patients with relapsed or refractory B-cell non-Hodgkin lymphoma.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.